Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
81 hedge funds and large institutions have $282M invested in Flexion Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 11 reducing their positions, and 8 closing their positions.
245% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 11
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
126% more capital invested
Capital invested by funds: $125M → $282M (+$157M)
25% more funds holding
Funds holding: 65 → 81 (+16)
57% less call options, than puts
Call options by funds: $437K | Put options by funds: $1.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$11.9M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$11.7M |
| 3 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$8.98M |
| 4 |
Bank of New York Mellon
New York
|
+$7.84M |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$5.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.65M |
| 2 |
Millennium Management
New York
|
-$1.25M |
| 3 |
Renaissance Technologies
New York
|
-$1.15M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.06M |
| 5 |
D.E. Shaw & Co
New York
|
-$854K |
FLXN Hedge Fund Activity: Q2 2016 in Review
81 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2016, worth a combined $282M — up 126% from $125M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new FLXN positions and 8 closed out — a net gain of 17 holders — while 38 added to existing stakes and 11 trimmed.
The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $11.9M. The largest seller was Invesco, exiting entirely with an estimated $1.65M sold.
- 81 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2016, up from 65 in Q1 2016.
- Funds reported $282M of Flexion Therapeutics, Inc. stock for Q2 2016, up 126% quarter-over-quarter.
- 25 funds opened new Flexion Therapeutics, Inc. positions in Q2 2016 and 8 closed out, a net change of +17 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2016 was Novo Holdings A/S, an estimated $11.9M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2016 was Invesco, an estimated $1.65M sold.
Based on aggregated 13F filings for Q2 2016.